Testimony Before the FDA’s Vaccines and Related Biological Products Advisory Committee Regarding the EUA of the Pfizer-BioNTech COVID-19 Vaccine
In testimony before a meeting of the Food and Drug Administration’s (FDA’s) Vaccines and Related Biological Products Advisory Committee, Public Citizen agreed with the need for an Emergency Use Authorization (EUA) for the Pfizer-BioNTech COVID-19 vaccine, but argued that for ethical reasons, subjects in the placebo group for the pivotal clinical trial should be offered the opportunity to be unblinded, receive the Pfizer vaccine, and continue to be followed in the trial for long-term safety and efficacy assessments.
See Public Citizen’s other work on the coronavirus pandemic.